Tenon Medical, Inc.
TNON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 108% | -22.3% | -5.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 65.9% | 43.4% | 44.5% | 45.8% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $4 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $2 | $1 | $2 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $3 | $4 | $4 |
| Operating Income | -$3 | -$3 | -$4 | -$3 |
| % Margin | -289.2% | -506.6% | -506.5% | -412.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$3 | -$3 | -$4 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$3 | -$4 | -$3 |
| % Margin | -284.7% | -491% | -498.1% | -400.9% |
| EPS | -0.4 | -0.36 | -1.01 | -2.54 |
| % Growth | -11.1% | 64.4% | 60.2% | – |
| EPS Diluted | -0.4 | -0.36 | -1.01 | -2.54 |
| Weighted Avg Shares Out | 8 | 8 | 4 | 1 |
| Weighted Avg Shares Out Dil | 8 | 8 | 4 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$4 | -$3 |
| % Margin | -272.3% | -470.7% | -483.3% | -396.9% |